Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
Clinical trial NCT00694850 · COMPLETED
Trial details
- NCT number
- NCT00694850
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-02
- Primary completion
- 2025-07-03
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.